episode-header-image

Mar 2024

12m 35s

Age Impact on Antidepressant Outcomes

Psychopharmacology Institute

About this episode

In this episode, we discuss an insightful study by Strawn et al. that utilized a mega-analysis approach, combining data on over 900 MDD patients across lifespan treatment trials to elucidate differences in antidepressant treatment outcomes based on patient age. Does antidepressant efficacy differ across developmental stages—children, adolescents, and adults?

Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.

Up next

Clozapine and Compulsions: New Research On An Old Side Effect

In this episode, we explore the puzzling connection between clozapine and obsessive-compulsive symptoms in schizophrenia patients. Does this wonder drug actually cause OCD, or are we missing a deeper story about how protective behaviors transform into compulsive habits? Faculty: ... Show More

Naltrexone vs. Topiramate: FDA-Approved vs. Off-Label Options for MAUD

In this episode, we explore groundbreaking head-to-head research comparing topiramate and naltrexone for alcohol use disorder, revealing surprising equivalence in effectiveness. Could the off-label option actually be as good as our FDA-approved standard for treating problematic d ... Show More

Beyond Tapering: Supporting Patients Through Benzodiazepine Discontinuation

In this episode, we discuss the critical challenges of benzodiazepine discontinuation, exploring Benzodiazepine-Induced Neurological Dysfunction (BIND) and effective support strategies for patients experiencing protracted withdrawal. What can clinicians do when over 50% of patien ... Show More

Recommended Episodes

Antidepressants and young people

From 2008 to 2018, the prescription of antidepressants in young people grew by 66 per cent. There’s data to suggest that last year, among the lockdowns and anxiety of the pandemic, that figure ticked even higher. In last week’s episode we looked at how the mental health of teenag ... Show More

Depression und Antidepressiva: Fragliche Ursache, fragliche Wirkung

mit Britta Verlinden und Philipp Winghart Monoaminmangelhypothese: Studienlage und alternative Erklärungsmodelle Inhaltsverzeichnis: 00:00 Intro 02:59 Die Monoaminmangelhypothese 06:58 Grenzen der Hypothese 10:38 Depression ist nicht gleich Depression 16:48 Die Monoaminrezeptorhy ... Show More

Treating the Depressed Brain

Nearly one in five US adults are diagnosed with depression at some point in their lives. As the use of antidepressants have steadily risen since their introduction in the 1980s, what have we learned about depression? Is depression truly a “chemical imbalance” of the brain? And wh ... Show More

Adderall, Stimulants & Modafinil for ADHD: Short- & Long-Term Effects

In this episode, I explain how medications such as Adderall, Ritalin, Vyvanse and other stimulants work to increase focus and treat attention-deficit/hyperactivity disorder (ADHD). I explain the brain circuits involved in focus and the key roles dopamine and norepinephrine play i ... Show More

#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the Interventions Testing Program

Richard Miller is a professor of pathology and the Director of the Center for Aging Research at the University of Michigan. He is one of the architects of the NIA-funded Interventions Testing Programs (ITPs) animal study test protocol. In this episode, Rich goes through the resul ... Show More

Mental Health Monthly #16: Psychosis in the ED Part II

Contributors: Andrew White MD & Travis Barlock MD In this follow-up episode Dr. Andrew White, a practicing psychiatrist with an addiction medicine fellowship, and Dr. Travis Barlock, an emergency physician at Swedish Medical Center, discuss mental health holds, psychiatric placem ... Show More

008 SP Do Antidepressants Work?

Antidepressants have been hailed as miracle drug rock stars and vilified as brain-changing happy pills. All promotion aside—good or bad—are they effective? Clinical psychologist Dr. Ellen Hendriksen digs through the data.

PsychEd Episode 62: Antipsychotic Side Effects with Dr. Alex Raben

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers Antipsychotic Side Effects with our very own expert Dr Alex Raben, a staff psychiatrist in chronic care at the Centre for Addiction and Mental Health in Toronto. Dr. Raben gr ... Show More

Probiotics Added to Antidepressants Improve Outcome: New Preliminary Research with Anna-Chiara Schaub (Basal, Switzerland)

"We have those two groups with the probiotics and the placebo. The patients were allocated to the two groups and it was double-blind so we didn’t know if they took the probiotics or the placebo. They took it for four weeks and we did the assessments before the intervention and af ... Show More

Podcast 863: Treatments for Alcohol Use Disorder

Contributor: Aaron Lessen MD Educational Pearls: Patients with alcohol use disorder are frequently discharged from the ED without further resources Pharmacological treatments to reduce cravings in AUD exist Naltrexone Effective at reducing alcohol cravings and heavy drinking Ga ... Show More

Listen to millions of songs and podcasts on Anghami